Unknown

Dataset Information

0

Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, India.


ABSTRACT:

Introduction

The incidence of SARS-CoV-2 re-infection has not been widely evaluated in low-income and middle-income countries. Understanding immune responses elicited by SARS-CoV-2 natural infection and factors that lead to re-infection in a community setting is important for public health policy. We aim to investigate the risk of primary infection and re-infection among those without and with evidence of prior infection as defined by the presence of antibodies to SARS-CoV-2 spike protein.

Methods and analysis

A baseline seroprevalence survey will test for SARS-CoV-2 antibodies among healthy adults in Vellore, India. Based on an expected seropositivity rate of 50% in the general population, with annual attack rates of 12%, 6%, 4.8% and 4% among those unvaccinated and seronegative, vaccinated and seronegative, unvaccinated and seropositive, and vaccinated and seropositive, respectively, we will recruit 1200 adults who will be followed up for a total of 24 months. Weekly self-collected saliva samples will be tested by reverse transcription-PCR (RT-PCR) to detect SARS-CoV-2 infections, for a period of 1 year. For any person testing RT-PCR positive, blood samples will be collected within 2 days of RT-PCR positivity and on days 30 and 90 to assess the kinetics and longevity of the antibody responses, B cell memory and T cell memory post-infection. The data will be analysed to estimate seroprevalence at baseline and over time, the risk factors for infection, rates of primary infection and re-infection, and provide a comparison of the rates across groups based on infection and vaccination status.

Ethics and dissemination

The study has been approved by the Institutional Review Board (IRB No: 13585) of Christian Medical College and Hospital, Vellore. The results of the study will be made available through journal publications and conference presentations.

Trial registration number

Central Trial Registry of India: CTRI/2020/11/029438.

SUBMITTER: Madhavan R 

PROVIDER: S-EPMC9130666 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, India.

Madhavan Ramya R   Paul Jackwin Sam JS   Babji Sudhir S   Kumar Dilesh D   Prabhu Savit B SB   Pulleri Harsha Kandi HK   Annadorai Ravikiran R   Gowda Sampreeth Ravi SR   John Jacob J   Kang Gagandeep G  

BMJ open 20220524 5


<h4>Introduction</h4>The incidence of SARS-CoV-2 re-infection has not been widely evaluated in low-income and middle-income countries. Understanding immune responses elicited by SARS-CoV-2 natural infection and factors that lead to re-infection in a community setting is important for public health policy. We aim to investigate the risk of primary infection and re-infection among those without and with evidence of prior infection as defined by the presence of antibodies to SARS-CoV-2 spike protei  ...[more]

Similar Datasets

| S-EPMC9764659 | biostudies-literature
| S-EPMC8987192 | biostudies-literature
| S-EPMC6552319 | biostudies-literature
| S-EPMC7058808 | biostudies-literature
| S-EPMC9294687 | biostudies-literature
| S-EPMC3062464 | biostudies-literature
| S-EPMC2473265 | biostudies-literature
| S-EPMC9365624 | biostudies-literature
| S-EPMC8027559 | biostudies-literature
| S-EPMC6617624 | biostudies-literature